NAD+ 500mg — Verification Report
From Voltera Sciences · Lot NAD.05.02.2026 · Tested May 2026
VialTalk
NAD+ 500mg
Voltera Sciences
Score
106.6
Grade
A++
Superlative
Lot NAD.05.02.2026
Tested May 2026
Report ID
5fb71c4e
Test
Method
Result
Status
PurityFull credit
HPLC
99.86%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentStrong
Gravimetric vs label claim
500 mg labeled · 517.42 mg tested
Strong
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityFull credit
USP <71> compendial
Screened
Full credit
Batch conformityPartial
Two-batch average
Assessed
Partial
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/voltera-sciences/coas/5fb71c4e-aad5-4371-ba13-e968abf98de5